Abagovomab
Term · Oncology and biomedicine · MLC-T-ONC-009569
A murine IgG1 monoclonal anti-idiotype antibody, containing a variable antigen-binding region that functionally mimics the three-dimensional structure of a specific epitope on the ovarian cancer tumor-associated antigen CA-125, with potential antineoplastic activity. With a variable antigen-binding region that acts as a surrogate antigen for CA-125, abagovomab may stimulate the host immune system to elicit humoral and cellular immune responses against CA-125-positive tumor cells, resulting in inhibition of tumor cell proliferation.
| Identifier | MLC-T-ONC-009569 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | monoclonal antibody ACA125 anti-idiotype vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009569",
"term": "Abagovomab",
"field": "Oncology and biomedicine",
"definition": "A murine IgG1 monoclonal anti-idiotype antibody, containing a variable antigen-binding region that functionally mimics the three-dimensional structure of a specific epitope on the ovarian cancer tumor-associated antigen CA-125, with potential antineoplastic activity. With a variable antigen-binding region that acts as a surrogate antigen for CA-125, abagovomab may stimulate the host immune system to elicit humoral and cellular immune responses against CA-125-positive tumor cells, resulting in inhibition of tumor cell proliferation.",
"synonyms": [
"monoclonal antibody ACA125 anti-idiotype vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/abagovomab/"
}
Record 149 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.